1. G3BP1 knockdown sensitizes U87 glioblastoma cell line to Bortezomib by inhibiting stress granules assembly and potentializing apoptosis
- Author
-
I. B. S. Souza, Graziele L. Negreiros-Lima, Lirlândia P. Sousa, Miriane Fernandes Dutra, Waleska Kerllen Martins, A. G. Silva, R. F. Silva, Lucíola S. Barcelos, Rosy Iara Maciel de Azambuja Ribeiro, Ana Carolina Fialho Dias, Lucas Felipe Fernandes Bittencourt, and Frederico Marianetti Soriani
- Subjects
Cancer Research ,Angiogenesis ,Antineoplastic Agents ,Apoptosis ,Cytoplasmic Granules ,Bortezomib ,03 medical and health sciences ,0302 clinical medicine ,Stress granule ,Temozolomide ,Tumor Cells, Cultured ,medicine ,Humans ,U87 ,Poly-ADP-Ribose Binding Proteins ,Antineoplastic Agents, Alkylating ,Cell Proliferation ,Gene knockdown ,Neovascularization, Pathologic ,business.industry ,Glioblastoma cell line ,DNA Helicases ,RNA Recognition Motif Proteins ,Neurology ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,Neurology (clinical) ,Glioblastoma ,business ,RNA Helicases ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Glioblastoma multiforme (GBM) is the most lethal form of gliomas. New therapies are currently in development to tackle treatment limitations such as chemotherapy resistance. One mechanism of resistance may be the stress granules (SG) assembly, a stress-related cellular response that allows cells to recruit and protect mRNAs during stress. SG are composed of various proteins, being G3BP1 a core element that enucleates and results in SG assembly. Here, we aimed to evaluate the effects of inhibiting the G3PB1 expression in the chemotherapeutical-induced cell death of the U87 glioblastoma cell line.G3BP1 mRNA and protein expression were modulated with short-interference RNA (siRNA). The viability of U87 cells after Bortezomib (BZM), a proteasome inhibitor, and Temozolomide (TMZ), an alkylating agent, was assessed by MTT assay. Apoptosis was evaluated by staining cells with Annexin-V/7-AAD and analyzing by flow cytometry. Caspase-3 activation was evaluated by immunoblotting. The chorioallantoic membrane in vivo assay was used to evaluate angiogenesis.When G3BP1 was knocked-down, the SG assembly was reduced and the BZM-treated cells, but not TMZ-treated cells, had a significant increase in the apoptotic response. Corroborating this data, we observed increased Caspase-3 activation in the BZM-treated and G3BP1-knocked-down cells when compared to vehicle-treated and scramble-transfected cells. Worth mentioning, the conditioned culture medium of G3BP1-knocked-down BZM-treated cells inhibited angiogenesis when compared to controls.Our data suggest G3BP1 knockdown diminishes SG formation and stimulates BZM-induced apoptosis of U87 cells in vitro, in addition to inhibiting glioblastoma-induced angiogenesis in vivo.
- Published
- 2019
- Full Text
- View/download PDF